Gary Wilkinson
Impact in
-
- PARP inhibition in cancer therapy
-
- Multiple Myeloma Research and Treatments
Papers in
-
- DNA Repair Mechanisms 5
- Cancer therapeutics and mechanisms 3
- Protein Degradation and Inhibitors 2
- Oncology 7
- Cancer-related Molecular Pathways 3
- PARP inhibition in cancer therapy 3
- Cancer Treatment and Pharmacology 2
- Co-authors
- Rajesh Odedra (2 shared papers)Thomas M. McGuire (2 shared papers)Paul Turner (2 shared papers)Kevin Blades (2 shared papers)Kevin M. Foote (2 shared papers)James Yates (2 shared papers)Christine Wood (2 shared papers)Philip J. Jewsbury (2 shared papers)
- Journals
- MedChemComm (3 papers)European Journal of Cancer (3 papers)Cancer Research (3 papers)Blood (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Gary Wilkinson
21 papers receiving 570 citations
Peers
Comparison fields: 5 of 59
- Oncology 167
- Hematology 50
- Organic Chemistry 132
- Molecular Biology 306
- Pharmacology 26
Countries citing papers authored by Gary Wilkinson
This map shows the geographic impact of Gary Wilkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Wilkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Wilkinson more than expected).
Fields of papers citing papers by Gary Wilkinson
This network shows the impact of papers produced by Gary Wilkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Wilkinson. The network helps show where Gary Wilkinson may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary Wilkinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 239 | |
| 2 | 2019 | 75 | |
| 3 | 2019 | 74 | |
| 4 | 2013 | 32 | |
| 5 | 2019 | 27 | |
| 6 | 2004 | 19 | |
| 7 | 2016 | 14 | |
| 8 | 2021 | 12 | |
| 9 | 2015 | 11 | |
| 10 | 2019 | 10 | |
| 11 | 2013 | 9 | |
| 12 | 2019 | 9 | |
| 13 | 2022 | 9 | |
| 14 | 2013 | 9 | |
| 15 | Impaired elimination of meperidine in patients with liver disease. | 1974 | 9 |
| 16 | 2013 | 7 | |
| 17 | 2013 | 6 | |
| 18 | 2024 | 5 | |
| 19 | 1951 | 4 | |
| 20 | 2022 | 3 |
About Gary Wilkinson
Gary Wilkinson is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Surgery and Hematology, having authored 23 papers that have together received 584 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (5 papers), Cancer-related Molecular Pathways (3 papers), PARP inhibition in cancer therapy (3 papers), Prostate Cancer Treatment and Research (3 papers), Cancer therapeutics and mechanisms (3 papers), Pancreatic function and diabetes (3 papers), Protein Degradation and Inhibitors (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Oncology (167 citations), Hematology (50 citations), Organic Chemistry (132 citations), Molecular Biology (306 citations) and Pharmacology (26 citations). Gary Wilkinson has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Rajesh Odedra, Thomas M. McGuire, Paul Turner, Kevin Blades, Kevin M. Foote, James Yates, Christine Wood, Philip J. Jewsbury, Sylvie M. Guichard and Alan Lau. Their work appears in journals such as MedChemComm, European Journal of Cancer, Cancer Research, Blood and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.